Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming ...
An executive at Tarsus Pharmaceuticals sold 12,274 shares for a transaction value of approximately $839,000, based on a weighted average price of $68.36 per share across three days ending March 19, ...
Modern Vision Solutions has announced the publication of a new article, “Demodex Blepharitis Treatment in Omaha,” highlighting a significant shift in how optometrists approach the treatment of chronic ...
The dosage of Xdemvy (lotilaner ophthalmic solution) for Demodex blepharitis is typically 1 drop per eye twice daily for 6 weeks. It’s important to take the Xdemvy dosage your doctor prescribes.